Abbott India spurts after good Q1 outcome

Abbott India rose 6.53% to Rs 4815 at 15:01 IST on BSE after net profit rose 34.62% to Rs 68.56 crore on 20.58% rise in net sales to Rs 623.28 crore in Q1 June 2015 over Q1 June 2014.

The result was announced after trading hours yesterday, 12 August 2015.

Meanwhile, the BSE Sensex was up 90.32 points, or 0.33%, to 27,602.58.

On BSE, so far 2,042 shares were traded in the counter, compared with an average volume of 705 shares in the past one quarter.

The stock hit a high of Rs 4,806 and a low of Rs 4,680 so far during the day. The stock hit a record high of Rs 4,866.15 on 7 August 2015. The stock hit a 52-week low of Rs 2,063.70 on 13 August 2014.

The stock had outperformed the market over the past one month till 12 August 2015, rising 12.98% compared with 0.54% fall in the Sensex. The scrip had also outperformed the market in past one quarter, rising 17.31% as against Sensex's 2.36% rise.

The mid-cap company has an equity capital of Rs 21.25 crore. Face value per share is Rs 10.

Abbott India is one of India's fastest growing pharmaceutical companies. The company enjoys strong brand equity in multiple therapeutic categories such as women's health, gastroenterology, neurology, thyroid, diabetes & urology pain management, vitamins, anti-infectives & other therapy areas.

Powered by Capital Market - Live News